文献
J-GLOBAL ID:201802228709573698
整理番号:18A1633276
再発/難治性多発性骨髄腫患者におけるレナリドミドとデキサメタゾンの臨床アウトカム
The clinical outcomes of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
著者 (10件):
LEE Ho Sup
(Kosin Univ. Coll. of Medicine, Busan, KOR)
,
MIN Chang-Ki
(Catholic Univ. Korea, Seoul, KOR)
,
KIM Kihyun
(Sunkyunkwan Univ. School of Medicine, Seoul, KOR)
,
LEE Je-Jung
(Chonnam National Univ. Hwasun Hospital, Jeollanamdo, KOR)
,
YOON Sung-Soo
(Seoul National Univ. Hospital, Seoul, KOR)
,
KIM Hyo Jung
(Hallym Univ. Coll. of Medicine, Anyang, KOR)
,
KIM Jin Seok
(Yonsei Univ. Coll. of Medicine, Seoul, KOR)
,
Hyeon-Seok Hyeon-Seok
(National Cancer Center of Korea, Goyang, KOR)
,
KIM Sung-Hyun
(Dong-A Univ. Coll. of Medicine, Busan, KOR)
,
PARK Seong Kyu
(Soonchunhyang Univ. Bucheon Hospital, Bucheon, KOR)
資料名:
International Journal of Myeloma (Web)
(International Journal of Myeloma (Web))
巻:
8
号:
2
ページ:
88 (WEB ONLY)
発行年:
2018年
JST資料番号:
U0465A
ISSN:
2187-3143
資料種別:
逐次刊行物 (A)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)